Karasawa A - Search Results

1

Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.

Karasawa A, Kawakage M, Shirakura S, Higo K, Kubo K, Ohshima E, Obase H. Karasawa A, et al. Arzneimittelforschung. 1991 Dec;41(12):1230-6. Arzneimittelforschung. 1991. PMID: 1840011

2

Protective effect of KW-3635, a specific thromboxane A2-receptor antagonist, on experimental glomerulonephritis in mice.

Kawakage M, Sato K, Karasawa A. Kawakage M, et al. Among authors: karasawa a. Jpn J Pharmacol. 1994 Jun;65(2):163-6. doi: 10.1254/jjp.65.163. Jpn J Pharmacol. 1994. PMID: 7967228 Free article.

3

Antithrombotic effects of KW-3635, a thromboxane A2-receptor antagonist, in guinea pigs.

Shirakura S, Higo K, Takeda M, Karasawa A. Shirakura S, et al. Among authors: karasawa a. Jpn J Pharmacol. 1994 Jun;65(2):93-8. doi: 10.1254/jjp.65.93. Jpn J Pharmacol. 1994. PMID: 7967232 Free article.

4

The novel thromboxane A2 receptor antagonist KW-3635 abolishes the cyclic flow reduction in the canine carotid artery.

Higo K, Karasawa A. Higo K, et al. Among authors: karasawa a. Biol Pharm Bull. 1994 Jul;17(7):902-6. doi: 10.1248/bpb.17.902. Biol Pharm Bull. 1994. PMID: 8000373 Free article.

5

Protective effects of KW-3635, a thromboxane A2 antagonist, on arachidonic acid-induced transient cerebral ischemia in dogs.

Satoh H, Kobayashi T, Higo K, Karasawa A. Satoh H, et al. Among authors: karasawa a. Jpn J Pharmacol. 1994 May;65(1):45-50. doi: 10.1254/jjp.65.45. Jpn J Pharmacol. 1994. PMID: 8089929 Free article.

6

Effects of KW-3635, a specific thromboxane A2-receptor antagonist, on the development of lupus nephritis in NZB x NZW F1 mice.

Kawakage M, Mizumoto H, Nukui E, Sato S, Karasawa A. Kawakage M, et al. Among authors: karasawa a. Jpn J Pharmacol. 1993 Dec;63(4):433-8. doi: 10.1254/jjp.63.433. Jpn J Pharmacol. 1993. PMID: 8121078 Free article.

7

Inhibitory effect of KW-3635, a new thromboxane A2-receptor antagonist, on arterial thrombosis in guinea pigs.

Higo K, Karasawa A. Higo K, et al. Among authors: karasawa a. Jpn J Pharmacol. 1993 Dec;63(4):521-3. doi: 10.1254/jjp.63.521. Jpn J Pharmacol. 1993. PMID: 8121085 Free article.

8

The novel thromboxane A2 receptor antagonist KW-3635 reduces infarct size in a canine model of coronary occlusion and reperfusion.

Higo K, Sano J, Karasawa A, Kubo K. Higo K, et al. Among authors: karasawa a. Arch Int Pharmacodyn Ther. 1993 May-Jun;323:32-49. Arch Int Pharmacodyn Ther. 1993. PMID: 8250642

9

Dibenzoxepin derivatives: thromboxane A2 synthase inhibition and thromboxane A2 receptor antagonism combined in one molecule.

Ohshima E, Sato H, Obase H, Miki I, Ishii A, Kawakage M, Shirakura S, Karasawa A, Kubo K. Ohshima E, et al. Among authors: karasawa a. J Med Chem. 1993 May 28;36(11):1613-8. doi: 10.1021/jm00063a011. J Med Chem. 1993. PMID: 8496929

10

Non-prostanoid thromboxane A2 receptor antagonists with a dibenzoxepin ring system. 1.

Ohshima E, Takami H, Sato H, Obase H, Miki I, Ishii A, Karasawa A, Kubo K. Ohshima E, et al. Among authors: karasawa a. J Med Chem. 1992 Sep 4;35(18):3394-402. doi: 10.1021/jm00096a016. J Med Chem. 1992. PMID: 1388207

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters